Dapagliflozin Audit ADA New Orleans, June 2016a - Poster

Does dapagliflozin affect the metabolic response in patients with elevated alanine aminotransferase (ALT) and Type 2 diabetes?: the Association of British Clinical Diabetologists (ABCD) nationwide dapagliflozin audit

M.Yadagiri¹, P S Gupta¹, M L Cull¹, D Price², V Oguntolu³, K Imtiaz⁴, D Barnes⁵, A Nugent⁶, A Robinson⁷, I W Gallen⁸, K A Adamson⁹, R E J Ryder¹, the ABCD nationwide dapagliflozin audit contributors¹⁰

¹Sandwell and West Birmingham NHS Trust Hospital, Birmingham, UK

²Abertawe Bro Morgannwg University NHS Trust, Swansea, UK

³The Royal Wolverhampton NHS Trust, Wolverhampton, UK

⁴East Lancashire Hospitals NHS Trust, Chorley, UK

⁵Maidstone And Tunbridge Wells NHS Trust, Tunbridge Wells, UK

⁶Belfast City Hospital, Belfast, UK

⁷Royal United Bath Hospital, Bath,UK

⁸Berkshire West CCG, Reading, UK

⁹West Lothian NHS Trust, Livingston, UK

¹⁰Various Hospitals and health centres, various towns, UK